Licensing opportunity from NIH: chimeric protein with potential as antiinfective therapeutic June 22, 2001
Mutant HLA class I molecules as novel approach to xenotransplantation and bone marrow transplant June 15, 2001
CIPF obtains rights to antigen delivery technology for anticancer, antiinfectious applications June 15, 2001
AUA news: FimCH vaccine protects against challenge with invasive pyelonephritic E. coli June 14, 2001
Vaxfectin enhances humoral immune response without affecting cell-mediated response to pDNA vaccines June 13, 2001